The table below shows Arcus Biosciences, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$17.00M
$26.00M
$160.00M
$28.00M
$48.00M
$39.00M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$122.00M
$141.00M
$139.00M
$122.00M
$123.00M
$115.00M
RCUS annual revenue (10-K history)
Arcus Biosciences, Inc. reported annual revenue of $247.00M for fiscal year 2025. That is down 4.3% from $258.00M in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $1.41M (FY 2017) to $247.00M. Figures come from the company's audited annual reports as filed with the SEC.
